News on Rebif from BioPortfolio.com http://www.BioPortfolio.com Consolidated Rebif news from BioPortfolio.com Tue, 09 Feb 2010 21:18:19 GMT en Study to look at earlier use of MS drug Tysabrihttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035201&HITNO=0&MSIZE=71&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Rebif&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035201&THISHREF=http://c.moreover.com/click/here.pl%3fz2536156713%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035201&HITNO=0&MSIZE=71&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Rebif&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035201&THISHREF=http://c.moreover.com/click/here.pl%3fz2536156713%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Times: Biogen Plans First Study For Earlier Use Of MS Drug Tysabrihttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024069&HITNO=1&MSIZE=71&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Rebif&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024069&THISHREF=http://c.moreover.com/click/here.pl%3fz2528617047%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024069&HITNO=1&MSIZE=71&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Rebif&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024069&THISHREF=http://c.moreover.com/click/here.pl%3fz2528617047%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFOXBusiness.com: Biogen Plans First Study For Earlier Use Of MS Drug Tysabrihttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024020&HITNO=2&MSIZE=71&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Rebif&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024020&THISHREF=http://c.moreover.com/click/here.pl%3fz2528578603%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024020&HITNO=2&MSIZE=71&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Rebif&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024020&THISHREF=http://c.moreover.com/click/here.pl%3fz2528578603%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFOXNews.com: Biogen Plans First Study For Earlier Use Of MS Drug Tysabrihttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4023798&HITNO=3&MSIZE=71&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Rebif&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4023798&THISHREF=http://c.moreover.com/click/here.pl%3fz2528409971%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4023798&HITNO=3&MSIZE=71&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Rebif&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4023798&THISHREF=http://c.moreover.com/click/here.pl%3fz2528409971%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMorningstar.com: Biogen Plans First Study For Earlier Use Of MS Drug Tysabrihttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4023714&HITNO=4&MSIZE=71&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Rebif&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4023714&THISHREF=http://c.moreover.com/click/here.pl%3fz2528357107%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4023714&HITNO=4&MSIZE=71&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Rebif&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4023714&THISHREF=http://c.moreover.com/click/here.pl%3fz2528357107%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNasdaq: Biogen Plans First Study For Earlier Use Of MS Drug Tysabrihttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4023711&HITNO=5&MSIZE=71&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Rebif&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4023711&THISHREF=http://c.moreover.com/click/here.pl%3fz2528353067%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4023711&HITNO=5&MSIZE=71&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Rebif&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4023711&THISHREF=http://c.moreover.com/click/here.pl%3fz2528353067%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNasdaq: PROLOR Biotech Reports Positive Results From Comparative Study Of Its Longer-Acting Version Of Multiple Sclerohttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3962878&HITNO=6&MSIZE=71&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Rebif&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3962878&THISHREF=http://c.moreover.com/click/here.pl%3fz2497515755%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3962878&HITNO=6&MSIZE=71&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Rebif&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3962878&THISHREF=http://c.moreover.com/click/here.pl%3fz2497515755%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedical News Today: PROLOR Biotech Reports Positive Results From Comparative Study Of Its Longer-Acting Version Of Multiple Sclerosis Drug Interferon Beta In Primateshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3962195&HITNO=7&MSIZE=71&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Rebif&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3962195&THISHREF=http://c.moreover.com/click/here.pl%3fz2497094663%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3962195&HITNO=7&MSIZE=71&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Rebif&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3962195&THISHREF=http://c.moreover.com/click/here.pl%3fz2497094663%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaceutical Online: No Way to Hide This Drug Approvalhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3958652&HITNO=8&MSIZE=71&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Rebif&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3958652&THISHREF=http://c.moreover.com/click/here.pl%3fz2495485052%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3958652&HITNO=8&MSIZE=71&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Rebif&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3958652&THISHREF=http://c.moreover.com/click/here.pl%3fz2495485052%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMotley Fool via MSN Money: Tysabri Updates: All You Have to Do Is Askhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3958620&HITNO=9&MSIZE=71&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Rebif&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3958620&THISHREF=http://c.moreover.com/click/here.pl%3fz2495472841%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3958620&HITNO=9&MSIZE=71&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Rebif&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3958620&THISHREF=http://c.moreover.com/click/here.pl%3fz2495472841%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMotley Fool via MSN Money: No Way to Hide This Drug Approvalhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3958613&HITNO=10&MSIZE=71&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Rebif&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3958613&THISHREF=http://c.moreover.com/click/here.pl%3fz2495469815%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3958613&HITNO=10&MSIZE=71&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Rebif&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3958613&THISHREF=http://c.moreover.com/click/here.pl%3fz2495469815%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMotley Fool: Tysabri Updates: All You Have to Do Is Askhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3958595&HITNO=11&MSIZE=71&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Rebif&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3958595&THISHREF=http://c.moreover.com/click/here.pl%3fz2495458958%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3958595&HITNO=11&MSIZE=71&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Rebif&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3958595&THISHREF=http://c.moreover.com/click/here.pl%3fz2495458958%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMotley Fool: PROLOR Biotech Reports Positive Results From Comparative Study of Its Longer-Acting Version of Multiple Sclerosis Drug Interferon Beta in Primateshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3957825&HITNO=12&MSIZE=71&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Rebif&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3957825&THISHREF=http://c.moreover.com/click/here.pl%3fz2495121908%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3957825&HITNO=12&MSIZE=71&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Rebif&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3957825&THISHREF=http://c.moreover.com/click/here.pl%3fz2495121908%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: PROLOR Biotech Reports Positive Results From Comparative Study of Its Longer-Acting Version of Multiple Sclerosis Drug Interferon Beta in Primateshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3957730&HITNO=13&MSIZE=71&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Rebif&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3957730&THISHREF=http://c.moreover.com/click/here.pl%3fz2495076389%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3957730&HITNO=13&MSIZE=71&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Rebif&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3957730&THISHREF=http://c.moreover.com/click/here.pl%3fz2495076389%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comcompaniesandmarkets.com: PROLOR Biotech Reports Positive Results From Comparative Study of Its Longer-Acting Version of Multiple Sclerosis Drug Interferon Beta in Primateshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3957359&HITNO=14&MSIZE=71&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Rebif&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3957359&THISHREF=http://c.moreover.com/click/here.pl%3fz2494931259%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3957359&HITNO=14&MSIZE=71&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Rebif&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3957359&THISHREF=http://c.moreover.com/click/here.pl%3fz2494931259%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comRed Orbit: